TRANSCAT INC (TRNS) Fundamental Analysis & Valuation

NASDAQ:TRNS • US8935291075

Current stock price

73.71 USD
+0.59 (+0.81%)
At close:
73.71 USD
0 (0%)
After Hours:

This TRNS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. TRNS Profitability Analysis

1.1 Basic Checks

  • In the past year TRNS was profitable.
  • TRNS had a positive operating cash flow in the past year.
  • In the past 5 years TRNS has always been profitable.
  • In the past 5 years TRNS always reported a positive cash flow from operatings.
TRNS Yearly Net Income VS EBIT VS OCF VS FCFTRNS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

1.2 Ratios

  • TRNS has a Return On Assets (1.67%) which is in line with its industry peers.
  • TRNS has a Return On Equity (2.66%) which is in line with its industry peers.
  • With a Return On Invested Capital value of 3.14%, TRNS is not doing good in the industry: 61.70% of the companies in the same industry are doing better.
  • The Average Return On Invested Capital over the past 3 years for TRNS is below the industry average of 9.20%.
Industry RankSector Rank
ROA 1.67%
ROE 2.66%
ROIC 3.14%
ROA(3y)4.66%
ROA(5y)5.25%
ROE(3y)7.28%
ROE(5y)9.09%
ROIC(3y)6%
ROIC(5y)6.74%
TRNS Yearly ROA, ROE, ROICTRNS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • TRNS's Profit Margin of 2.47% is in line compared to the rest of the industry. TRNS outperforms 44.68% of its industry peers.
  • In the last couple of years the Profit Margin of TRNS has grown nicely.
  • Looking at the Operating Margin, with a value of 5.60%, TRNS is in line with its industry, outperforming 53.19% of the companies in the same industry.
  • TRNS's Operating Margin has improved in the last couple of years.
  • TRNS's Gross Margin of 32.45% is fine compared to the rest of the industry. TRNS outperforms 63.83% of its industry peers.
  • In the last couple of years the Gross Margin of TRNS has grown nicely.
Industry RankSector Rank
OM 5.6%
PM (TTM) 2.47%
GM 32.45%
OM growth 3Y-2.14%
OM growth 5Y1.69%
PM growth 3Y-2.08%
PM growth 5Y2.27%
GM growth 3Y4.06%
GM growth 5Y5.54%
TRNS Yearly Profit, Operating, Gross MarginsTRNS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. TRNS Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TRNS is destroying value.
  • TRNS has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for TRNS has been increased compared to 5 years ago.
  • TRNS has a worse debt/assets ratio than last year.
TRNS Yearly Shares OutstandingTRNS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
TRNS Yearly Total Debt VS Total AssetsTRNS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • TRNS has an Altman-Z score of 3.52. This indicates that TRNS is financially healthy and has little risk of bankruptcy at the moment.
  • TRNS's Altman-Z score of 3.52 is fine compared to the rest of the industry. TRNS outperforms 61.70% of its industry peers.
  • TRNS has a debt to FCF ratio of 4.02. This is a neutral value as TRNS would need 4.02 years to pay back of all of its debts.
  • TRNS's Debt to FCF ratio of 4.02 is fine compared to the rest of the industry. TRNS outperforms 63.83% of its industry peers.
  • A Debt/Equity ratio of 0.34 indicates that TRNS is not too dependend on debt financing.
  • TRNS has a Debt to Equity ratio of 0.34. This is comparable to the rest of the industry: TRNS outperforms 57.45% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 4.02
Altman-Z 3.52
ROIC/WACC0.36
WACC8.71%
TRNS Yearly LT Debt VS Equity VS FCFTRNS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.3 Liquidity

  • A Current Ratio of 2.21 indicates that TRNS has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.21, TRNS is in the better half of the industry, outperforming 61.70% of the companies in the same industry.
  • TRNS has a Quick Ratio of 1.85. This is a normal value and indicates that TRNS is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.85, TRNS is in the better half of the industry, outperforming 76.60% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.21
Quick Ratio 1.85
TRNS Yearly Current Assets VS Current LiabilitesTRNS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. TRNS Growth Analysis

3.1 Past

  • TRNS shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -9.19%.
  • TRNS shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.36% yearly.
  • Looking at the last year, TRNS shows a quite strong growth in Revenue. The Revenue has grown by 17.45% in the last year.
  • The Revenue has been growing by 9.97% on average over the past years. This is quite good.
EPS 1Y (TTM)-9.19%
EPS 3Y-2.79%
EPS 5Y6.36%
EPS Q2Q%4%
Revenue 1Y (TTM)17.45%
Revenue growth 3Y10.75%
Revenue growth 5Y9.97%
Sales Q2Q%25.62%

3.2 Future

  • The Earnings Per Share is expected to grow by 17.15% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 8.45% on average over the next years. This is quite good.
EPS Next Y28.71%
EPS Next 2Y25.5%
EPS Next 3Y17.45%
EPS Next 5Y17.15%
Revenue Next Year19.68%
Revenue Next 2Y13.45%
Revenue Next 3Y9.11%
Revenue Next 5Y8.45%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
TRNS Yearly Revenue VS EstimatesTRNS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M
TRNS Yearly EPS VS EstimatesTRNS Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

2

4. TRNS Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 43.88 indicates a quite expensive valuation of TRNS.
  • Compared to the rest of the industry, the Price/Earnings ratio of TRNS indicates a slightly more expensive valuation: TRNS is more expensive than 61.70% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.11. TRNS is valued rather expensively when compared to this.
  • TRNS is valuated quite expensively with a Price/Forward Earnings ratio of 31.83.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of TRNS is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.12, TRNS is valued a bit more expensive.
Industry RankSector Rank
PE 43.88
Fwd PE 31.83
TRNS Price Earnings VS Forward Price EarningsTRNS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • TRNS's Enterprise Value to EBITDA ratio is in line with the industry average.
  • 68.09% of the companies in the same industry are more expensive than TRNS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 27.65
EV/EBITDA 18.21
TRNS Per share dataTRNS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • TRNS's earnings are expected to grow with 17.45% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.53
PEG (5Y)6.9
EPS Next 2Y25.5%
EPS Next 3Y17.45%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. TRNS Dividend Analysis

5.1 Amount

  • No dividends for TRNS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TRNS Fundamentals: All Metrics, Ratios and Statistics

TRANSCAT INC

NASDAQ:TRNS (3/18/2026, 4:30:01 PM)

After market: 73.71 0 (0%)

73.71

+0.59 (+0.81%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)02-03
Earnings (Next)05-18
Inst Owners96.34%
Inst Owner Change0.55%
Ins Owners0.98%
Ins Owner Change0%
Market Cap687.71M
Revenue(TTM)319.69M
Net Income(TTM)7.89M
Analysts80
Price Target103.36 (40.23%)
Short Float %4.8%
Short Ratio3.01
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-19.05%
Min EPS beat(2)-23.53%
Max EPS beat(2)-14.58%
EPS beat(4)2
Avg EPS beat(4)2.74%
Min EPS beat(4)-23.53%
Max EPS beat(4)46.44%
EPS beat(8)4
Avg EPS beat(8)4.49%
EPS beat(12)7
Avg EPS beat(12)2.23%
EPS beat(16)8
Avg EPS beat(16)1.87%
Revenue beat(2)2
Avg Revenue beat(2)0.8%
Min Revenue beat(2)0.17%
Max Revenue beat(2)1.44%
Revenue beat(4)3
Avg Revenue beat(4)1.06%
Min Revenue beat(4)-1.01%
Max Revenue beat(4)3.66%
Revenue beat(8)4
Avg Revenue beat(8)-1.56%
Revenue beat(12)6
Avg Revenue beat(12)-1.1%
Revenue beat(16)8
Avg Revenue beat(16)-0.67%
PT rev (1m)-2.25%
PT rev (3m)-2.25%
EPS NQ rev (1m)0.75%
EPS NQ rev (3m)-14.23%
EPS NY rev (1m)-4.87%
EPS NY rev (3m)-12.5%
Revenue NQ rev (1m)1.14%
Revenue NQ rev (3m)2.14%
Revenue NY rev (1m)1.52%
Revenue NY rev (3m)1.31%
Valuation
Industry RankSector Rank
PE 43.88
Fwd PE 31.83
P/S 2.15
P/FCF 27.65
P/OCF 17.51
P/B 2.32
P/tB N/A
EV/EBITDA 18.21
EPS(TTM)1.68
EY2.28%
EPS(NY)2.32
Fwd EY3.14%
FCF(TTM)2.67
FCFY3.62%
OCF(TTM)4.21
OCFY5.71%
SpS34.26
BVpS31.81
TBVpS-0.29
PEG (NY)1.53
PEG (5Y)6.9
Graham Number34.67
Profitability
Industry RankSector Rank
ROA 1.67%
ROE 2.66%
ROCE 4.1%
ROIC 3.14%
ROICexc 3.17%
ROICexgc 10.29%
OM 5.6%
PM (TTM) 2.47%
GM 32.45%
FCFM 7.78%
ROA(3y)4.66%
ROA(5y)5.25%
ROE(3y)7.28%
ROE(5y)9.09%
ROIC(3y)6%
ROIC(5y)6.74%
ROICexc(3y)6.37%
ROICexc(5y)6.98%
ROICexgc(3y)14.95%
ROICexgc(5y)15.39%
ROCE(3y)7.84%
ROCE(5y)8.8%
ROICexgc growth 3Y-9.42%
ROICexgc growth 5Y-3.25%
ROICexc growth 3Y-18.51%
ROICexc growth 5Y-11.8%
OM growth 3Y-2.14%
OM growth 5Y1.69%
PM growth 3Y-2.08%
PM growth 5Y2.27%
GM growth 3Y4.06%
GM growth 5Y5.54%
F-Score4
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 4.02
Debt/EBITDA 2.34
Cap/Depr 57.97%
Cap/Sales 4.51%
Interest Coverage 250
Cash Conversion 91.87%
Profit Quality 315.12%
Current Ratio 2.21
Quick Ratio 1.85
Altman-Z 3.52
F-Score4
WACC8.71%
ROIC/WACC0.36
Cap/Depr(3y)85.02%
Cap/Depr(5y)89.69%
Cap/Sales(3y)4.65%
Cap/Sales(5y)4.54%
Profit Quality(3y)129.96%
Profit Quality(5y)134.79%
High Growth Momentum
Growth
EPS 1Y (TTM)-9.19%
EPS 3Y-2.79%
EPS 5Y6.36%
EPS Q2Q%4%
EPS Next Y28.71%
EPS Next 2Y25.5%
EPS Next 3Y17.45%
EPS Next 5Y17.15%
Revenue 1Y (TTM)17.45%
Revenue growth 3Y10.75%
Revenue growth 5Y9.97%
Sales Q2Q%25.62%
Revenue Next Year19.68%
Revenue Next 2Y13.45%
Revenue Next 3Y9.11%
Revenue Next 5Y8.45%
EBIT growth 1Y-18.8%
EBIT growth 3Y8.38%
EBIT growth 5Y11.83%
EBIT Next Year192.7%
EBIT Next 3Y47.62%
EBIT Next 5Y32.49%
FCF growth 1Y34.44%
FCF growth 3Y51.16%
FCF growth 5Y38.93%
OCF growth 1Y31.51%
OCF growth 3Y30.31%
OCF growth 5Y27.52%

TRANSCAT INC / TRNS Fundamental Analysis FAQ

What is the fundamental rating for TRNS stock?

ChartMill assigns a fundamental rating of 4 / 10 to TRNS.


Can you provide the valuation status for TRANSCAT INC?

ChartMill assigns a valuation rating of 2 / 10 to TRANSCAT INC (TRNS). This can be considered as Overvalued.


What is the profitability of TRNS stock?

TRANSCAT INC (TRNS) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for TRNS stock?

The Price/Earnings (PE) ratio for TRANSCAT INC (TRNS) is 43.88 and the Price/Book (PB) ratio is 2.32.


What is the financial health of TRANSCAT INC (TRNS) stock?

The financial health rating of TRANSCAT INC (TRNS) is 5 / 10.